UK: FRESH FEARS OVER HOMOEOPATHY
Article Abstract:
There are fresh concerns in the UK regarding homoeopathy following the death of a baby from a treatable condition following the decision by the baby's parents to shun conventional medicine. The case comes as demand for alternative remedies in the UK increases with more alternative therapists in the UK than GPs. Although the demand for homoeopathy is on the increase, there are those that see the rise as a victory for superstition over science. However, it is recognised that homoeopathy is becoming increasingly popular, with many doctors now offering alternative treatments. Therefore, a call has been made to introduce regulations to the industry including a regulatory body that would keep a record of homoeopathic practitioners and procedures that would need to be met.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
UK: PROSTACYCLIN COST FOUR TIMES THAT IN US
Article Abstract:
UK pharmaceutical company Glaxo Wellcome 's prostacyclin drug used to treat primary pulmonary hypertension(PPH), a life-threatening lung disease, Costs four times as much in the UK as it does in the US. A course here costs GB[pound] 37,000 but only GB[pound] 9,000 in the US. Owing to the high cost only 80 UK patients are being treated with the drug, with a further 40 who need it being denied it. The high cost is blamed both on the lack of a single NHS purchasing system and the fact that it is only licensed for short-term use on kidney patients. Glaxo is currently applying for a licence for it to be used in PPH treatment here.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
UK: AN ATTEMPT TO END PRICE-FIXING OF DRUGS
Article Abstract:
The Office of Fair Trading (OFT) has attempted to end price-fixing of common medicines such as garlic supplements, paracetamol, and multivitamins. Prices are artificially high on items such as painkiller Nurofen, cold remedy Lemsip, and indigestion treatment Rennies. The OFT maintains that sales of branded medicine are less important as pharmacies are selling more non-drug products. In the past, the Restrictive Practices Court has ruled out changes to price-fixing, as it is believed that supermarket pharmacies would drop prices and village chemists would subsequently go out of business. A judgement is likely in early 2001.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
User Contributions:
Comment about this article or add new information about this topic: